During a live event, Ann F. Mohrbacher, MD, discussed outcomes from the latest follow-up of the ZUMA-7 and TRANSFORM trials.
Students’ access to digital devices has improved significantly as schools across the United States continue investing in technology infrastructure. A 2023 report from the National Center for Education ...
Intensity-modulated radiation therapy did not increase the risk for feeding tube dependence for patients with oropharyngeal ...
showsnob.com on MSN
Gen V season 2, episode 5 recap: Cipher is working with one of The Seven
We learn a little more about Cipher in Gen V season 2, episode 5, but it's not enough to figure him out. Take a look at the ...
Across the United States, more schools are implementing policies restricting cell phones as concerns about digital ...
But Why Tho? on MSN
RECAP: ‘Gen V’ Season 2 Episode 5 — “The Kids Are Not All Right”
Gen V Season 2 Episode 5 gets the momentum back after a brief slow-down, showing why the show is so compelling. The post ...
Regeneron Pharmaceuticals is seeing revenue growth in key products that is now offsetting declining revenue in its previous ...
HLA Protein Technologies, Inc. (formerly Pure Protein, LLC) reports that its new manufacturing expansion is positioned to ...
DuoCAR20.19.22-D95 targets CD19, CD20, and CD22, addressing antigen escape in B-cell malignancies like B-ALL and B-NHL. Early ...
Students at Oxford Hills Comprehensive High and Middle schools began the school year with a more restrictive phone and ...
Findings suggest bispecific CD3xCD20 therapy may offer an option for patients with Richter syndrome who are ineligible for transplant or CAR T-cell Therapy. A recent case report published in Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback